MCRB — Seres Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $124.58m
- $98.16m
- $126.33m
- 20
- 37
- 19
- 15
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 94.8 | 254 | 291 | 181 | 128 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.78 | 9.39 | 0 | — | 8.67 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 100 | 269 | 304 | 195 | 175 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 30.9 | 22.9 | 36.1 | 134 | 132 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 132 | 343 | 355 | 349 | 359 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 46 | 46.4 | 82.3 | 85.6 | 98.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 181 | 168 | 223 | 338 | 403 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -48.3 | 175 | 132 | 10.8 | -44.9 |
Total Liabilities & Shareholders' Equity | 132 | 343 | 355 | 349 | 359 |
Total Common Shares Outstanding |